Vaccine optimization for COVID-19: Who to vaccinate first?
Related Experiment Video
Updated: Nov 18, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
Laura Matrajt1, Julia Eaton2, Tiffany Leung3
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. laurama@fredhutch.org.
Insights
Vaccine allocation strategies are crucial for controlling COVID-19. Prioritizing older adults minimizes deaths with low-effectiveness vaccines, while younger groups are prioritized with high-effectiveness vaccines to reduce transmission.
Area of Science:
- Epidemiology
- Mathematical Modeling
- Public Health
Background:
- The COVID-19 pandemic necessitates effective control measures, with vaccines being a primary tool.
- Anticipated vaccine shortages require strategic allocation to maximize public health benefits.
- Mathematical modeling can inform optimal vaccine distribution strategies.
Purpose of the Study:
- To determine optimal vaccine allocation strategies to mitigate the COVID-19 pandemic under various scenarios.
- To evaluate the impact of vaccine effectiveness and coverage on allocation priorities.
- To provide an evidence-based rationale for vaccine prioritization.
Main Methods:
- An age-stratified mathematical model was developed to simulate COVID-19 transmission and outcomes.
- Optimization algorithms were employed to identify vaccine allocation strategies.
- Scenarios considered different vaccine effectiveness levels, vaccination coverages, and prioritization metrics (deaths, symptomatic infections, hospitalizations).
Main Results:
- A vaccine with effectiveness of 50% or higher can substantially mitigate the pandemic if optimally allocated and widely administered.
- For low vaccine effectiveness, prioritizing older, high-risk age groups is optimal for minimizing deaths, regardless of coverage.
- For high vaccine effectiveness and high vaccination coverage, prioritizing younger, high-transmission age groups becomes optimal for minimizing deaths.
Conclusions:
- Optimal vaccine allocation strategies are dynamic and depend on vaccine characteristics (effectiveness) and population behaviors (transmission patterns).
- Prioritizing high-risk groups is crucial for low-effectiveness vaccines, while prioritizing high-transmission groups can be more effective for high-effectiveness vaccines.
- This study provides a quantitative framework to support evidence-based decision-making for vaccine prioritization during pandemics.
Abstract:
Vaccines, when available, will likely become our best tool to control the COVID-19 pandemic. Even in the most optimistic scenarios, vaccine shortages will likely occur. Using an age-stratified mathematical model paired with optimization algorithms, we determined optimal vaccine allocation for four different metrics (deaths, symptomatic infections, and maximum non-ICU and ICU hospitalizations) under many scenarios. We find that a vaccine with effectiveness ≥50% would be enough to substantially mitigate the ongoing pandemic, provided that a high percentage of the population is optimally vaccinated. When minimizing deaths, we find that for low vaccine effectiveness, irrespective of vaccination coverage, it is optimal to allocate vaccine to high-risk (older) age groups first. In contrast, for higher vaccine effectiveness, there is a switch to allocate vaccine to high-transmission (younger) age groups first for high vaccination coverage. While there are other societal and ethical considerations, this work can provide an evidence-based rationale for vaccine prioritization.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Dosage Regimens: Designs and Approaches
Dosage Regimen: Individualization
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

